CYCLOSPORIN A
CMV
Fernanda P Silveira, MD, MSprotein_peptidePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the CMV cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Letermovir Fernanda P Silveira, MD, MS | Phase 2 | B |
aciclovir Fernanda P Silveira, MD, MS | Phase 2 | B |
Same molecule, other indications
CYCLOSPORIN A is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →